IPHA
Innate Pharma S.A.
NASDAQ · Healthcare · Biotechnology · FR
$2.08
−1.42%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 3.94x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -9.21x
- Price / sales
- 12.97x
- Price / cash flow
- -3.11x
Enterprise value
- Enterprise value
- $218.7M
- EV / sales
- 12.21x
- EV / EBITDA
- -1.83x
- EV / EBIT
- -1.79x
- Market cap
- $232.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025